| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.673 | 185.152 | 183.147 | 202.078 | - | 191.234 | 265.857 | 177.130 | 234.413 | 184.484 |
| Total Income - EUR | 38.995 | 186.730 | 181.132 | 201.500 | - | 198.285 | 258.963 | 177.825 | 237.961 | 218.705 |
| Total Expenses - EUR | 34.363 | 162.951 | 149.472 | 170.182 | - | 191.019 | 193.778 | 189.237 | 210.426 | 178.767 |
| Gross Profit/Loss - EUR | 4.632 | 23.779 | 31.660 | 31.318 | - | 7.265 | 65.186 | -11.412 | 27.536 | 39.938 |
| Net Profit/Loss - EUR | 3.798 | 19.388 | 29.971 | 29.297 | - | 5.411 | 62.751 | -12.928 | 25.322 | 34.306 |
| Employees | 1 | 4 | 4 | 4 | - | 5 | 4 | 4 | 3 | 2 |
Check the financial reports for the company - Deniagrotan Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.545 | 14.222 | 7.238 | 2.360 | - | 20.076 | 12.466 | 5.544 | 3.216 | 3.066 |
| Current Assets | 15.038 | 51.367 | 73.929 | 116.447 | - | 140.314 | 210.666 | 184.454 | 169.008 | 116.405 |
| Inventories | 2.321 | 16.179 | 20.896 | 21.113 | - | 65.152 | 80.608 | 86.112 | 69.638 | 25.868 |
| Receivables | 4.251 | 13.532 | 19.008 | 30.751 | - | 55.793 | 73.748 | 85.827 | 85.357 | 52.560 |
| Cash | 8.465 | 21.656 | 34.025 | 64.583 | - | 19.370 | 56.310 | 12.515 | 14.013 | 37.977 |
| Shareholders Funds | 3.834 | 24.329 | 53.888 | 82.196 | - | 114.586 | 174.795 | 140.915 | 165.810 | 90.038 |
| Social Capital | 45 | 45 | 44 | 43 | - | 41 | 40 | 41 | 40 | 80 |
| Debts | 40.748 | 41.261 | 27.279 | 36.611 | - | 45.804 | 48.337 | 49.083 | 6.414 | 29.433 |
| Income in Advance | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Deniagrotan Bio Srl